Annual EBITDA
-$883.80M$1.05B-616.54%
Summary
- Current Value
- As of today, NVST annual EBITDA is -$883.80M, down -616.54% on
- Historical Performance
- NVST annual EBITDA is down -291.92% over the past 3 years, and down -318.06% over the past 5 years
- All-Time High Comparison
- NVST annual EBITDA is currently -266.75% below its historical high of $530.00M set on
- 3-Year Low Comparison
- NVST annual EBITDA is at its 3-year low
- Sector Comparison
- NVST annual EBITDA is higher than 0.51% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$883.80M | -616.5% | -291.9% | -318.1% | -266.8% | |
| Quarterly EBITDA | $95.00M | +83.8% | -25.7% | -21.7% | +16.7% | |
| TTM EBITDA | $339.90M | +16.3% | -33.7% | +26.8% | +317.6% | |
| Price | $23.63 | +23.3% | -28.3% | -32.4% | – | |
| PE Ratio | 282.66 | – | +1049.0% | +30.0% | – | |
| Annual Revenue | $2.51B | -2.2% | +0.1% | -8.8% | -9.9% | |
| Annual EPS | -$6.50 | -981.9% | -450.9% | -507.2% | -478.9% | |
| Annual EBIT | -$1.04B | -10000.0% | -436.4% | -537.7% | -357.8% | |
| Annual Net Income | -$1.12B | -1016.4% | -524.5% | -614.1% | -511.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $484.40M | N/A | -282.4% |
| 5Y | $484.40M | -282.4% | |
| All | $530.00M | -266.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$883.80M | at low | |
| 5Y | -$883.80M | at low | |
| All | -$883.80M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$883.80M | -616.5% | |
| $171.10M | -64.7% | |
| $484.40M | +5.2% | |
| $460.50M | +124.0% | |
| $205.60M | -49.3% |
| Year | Value | Change |
|---|---|---|
| $405.30M | -6.0% | |
| $431.10M | -15.2% | |
| $508.10M | -4.1% | |
| $530.00M | - |
FAQ
What is the current annual EBITDA of NVST?
As of today, NVST annual EBITDA is -$883.80M
What is 1-year change in NVST annual EBITDA?
NVST annual EBITDA is down -616.54% year-over-year
What is 3-year change in NVST annual EBITDA?
NVST annual EBITDA is down -291.92% over the past 3 years
How far is NVST annual EBITDA from its all-time high?
NVST annual EBITDA is currently -266.75% below its historical high of $530.00M set on December 31, 2016
How does NVST annual EBITDA rank versus sector peers?
NVST annual EBITDA is higher than 0.51% of companies in Healthcare sector
When is NVST next annual earnings release?
The next annual earnings release for NVST is on
Quarterly EBITDA
$95.00M$14.40M+17.87%
Summary
- Current Value
- As of today, NVST quarterly EBITDA is $95.00M, up +17.87% on
- Historical Performance
- NVST quarterly EBITDA is up +83.75% year-over-year, and down -25.67% over the past 3 years
- All-Time High Comparison
- NVST quarterly EBITDA is currently -44.57% below its historical high of $171.40M set on
- 3-Year Low Comparison
- NVST quarterly EBITDA is +135.73% above its 3-year low of $40.30M reached on
- Sector Comparison
- NVST quarterly EBITDA is higher than 88.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $95.00M | +17.9% | +83.8% | -25.7% | -21.7% | |
| Annual EBITDA | -$883.80M | – | -616.5% | -291.9% | -318.1% | |
| TTM EBITDA | $339.90M | +14.6% | +16.3% | -33.7% | +26.8% | |
| Price | $23.63 | +17.0% | +23.3% | -28.3% | -32.4% | |
| PE Ratio | 282.66 | +17.0% | – | +1049.0% | +30.0% | |
| Quarterly Revenue | $669.90M | -1.8% | +11.5% | +6.2% | +22.4% | |
| Quarterly EPS | -$0.18 | -217.4% | -484.8% | -165.1% | -184.0% | |
| Quarterly EBIT | $65.80M | +29.5% | +192.4% | -23.1% | -16.5% | |
| Quarterly Net Income | -$30.30M | -214.8% | -469.5% | -161.1% | -228.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $95.00M | at high | |
| 3Y | $140.90M | N/A | -32.6% |
| 5Y | $171.40M | N/A | -44.6% |
| All | $171.40M | -44.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $77.20M | +23.1% | |
| 3Y | $40.30M | +135.7% | |
| 5Y | $40.30M | +135.7% | |
| All | $10.30M | +822.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NVST?
As of today, NVST quarterly EBITDA is $95.00M
What is NVST quarterly EBITDA most recent change?
NVST quarterly EBITDA was up +17.87% on September 26, 2025
What is 1-year change in NVST quarterly EBITDA?
NVST quarterly EBITDA is up +83.75% year-over-year
How far is NVST quarterly EBITDA from its all-time high?
NVST quarterly EBITDA is currently -44.57% below its historical high of $171.40M set on December 31, 2020
How does NVST quarterly EBITDA rank versus sector peers?
NVST quarterly EBITDA is higher than 88.51% of companies in Healthcare sector
When is NVST next earnings release?
The next earnings release for NVST is on
TTM EBITDA
$339.90M$43.30M+14.60%
Summary
- Current Value
- As of today, NVST TTM EBITDA is $339.90M, up +14.60% on
- Historical Performance
- NVST TTM EBITDA is up +16.28% year-over-year, and down -33.67% over the past 3 years
- All-Time High Comparison
- NVST TTM EBITDA is currently -40.21% below its historical high of $568.50M set on
- 3-Year Low Comparison
- NVST TTM EBITDA is +32.62% above its 3-year low of $256.30M reached on
- Sector Comparison
- NVST TTM EBITDA is higher than 88.33% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $339.90M | +14.6% | +16.3% | -33.7% | +26.8% | |
| Annual EBITDA | -$883.80M | – | -616.5% | -291.9% | -318.1% | |
| Quarterly EBITDA | $95.00M | +17.9% | +83.8% | -25.7% | -21.7% | |
| Price | $23.63 | +17.0% | +23.3% | -28.3% | -32.4% | |
| PE Ratio | 282.66 | +17.0% | – | +1049.0% | +30.0% | |
| TTM Revenue | $2.62B | +2.7% | +4.7% | +2.4% | +20.4% | |
| TTM EPS | $0.08 | -73.3% | +101.1% | -93.8% | +167.0% | |
| TTM EBIT | $225.20M | +23.8% | +50.4% | -36.4% | +97.4% | |
| TTM Net Income | $15.30M | -71.6% | +101.1% | -92.6% | +149.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $339.90M | at high | |
| 3Y | $522.50M | -35.0% | |
| 5Y | $568.50M | -40.2% | |
| All | $568.50M | -40.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $256.30M | +32.6% | |
| 3Y | $256.30M | +32.6% | |
| 5Y | $256.30M | +32.6% | |
| All | $81.40M | +317.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NVST?
As of today, NVST TTM EBITDA is $339.90M
What is NVST TTM EBITDA most recent change?
NVST TTM EBITDA was up +14.60% on September 26, 2025
What is 1-year change in NVST TTM EBITDA?
NVST TTM EBITDA is up +16.28% year-over-year
How far is NVST TTM EBITDA from its all-time high?
NVST TTM EBITDA is currently -40.21% below its historical high of $568.50M set on September 1, 2021
How does NVST TTM EBITDA rank versus sector peers?
NVST TTM EBITDA is higher than 88.33% of companies in Healthcare sector
When is NVST next earnings release?
The next earnings release for NVST is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- NVST Official Website envistaco.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1757073/000175707325000058/0001757073-25-000058-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1757073/000175707325000007/0001757073-25-000007-index.htm
- NVST Profile on Yahoo Finance finance.yahoo.com/quote/NVST
- NVST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvst